Log in to your Inderes Free account to see all free content on this page.
BBS-Bioactive Bone Substitutes
0.048
EUR
-6.23 %
Corporate customer
BONEH
First North Finland
Medical Equipment & Services
Health Care
3,940 following
-6.23%
-34.15%
-84.35%
-84.77%
-89.56%
-88.51%
-97.13%
-96.11%
-98.32%
BBS-Bioactive Bone Substitutes is a medical technology company. The company designs, develops and constructs biological implants for patients with bone defects and healing problems. The company's solutions are resold under the Artebone brand and are based on tricalcium phosphate (TCP) and bone protein, which stimulates the bone healing process. The company was founded in 2003 and is headquartered in Oulu.
Read moreMarket cap
1.35M EUR
Turnover
6.08K EUR
P/E (adj.) (24e)
EV/EBIT (adj.) (24e)
P/B (24e)
EV/S (24e)
Dividend yield-% (24e)
Coverage
Financial calendar
21.2.
2025
Annual report '24
29.4.
2025
General meeting '24
29.8.
2025
Interim report Q2'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
